K. U. Weithmann
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
-
- Peptidase Inhibition and Analysis
Papers in
- Oncology 8
- Peptidase Inhibition and Analysis 5
- Co-authors
- Alex Sevanian (2 shared papers)K. Ulrich Wendt (2 shared papers)Paul Hochstein (1 shared paper)Bernard Pirard (1 shared paper)Reinhard Kirsch (1 shared paper)Otmar Klingler (1 shared paper)Jörg Habermann (1 shared paper)Christian K. Engel (1 shared paper)
- Journals
- Inflammation Research (3 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Biochemical Journal (1 paper)Thrombosis and Haemostasis (1 paper)European Journal of Pharmacology (1 paper)
- Partner nations
- GermanyUnited StatesSlovenia
In The Last Decade
K. U. Weithmann
19 papers receiving 511 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 210
- Oncology 186
- Hematology 71
- Nephrology 37
- Immunology and Allergy 31
Countries citing papers authored by K. U. Weithmann
This map shows the geographic impact of K. U. Weithmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. U. Weithmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. U. Weithmann more than expected).
Fields of papers citing papers by K. U. Weithmann
This network shows the impact of papers produced by K. U. Weithmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. U. Weithmann. The network helps show where K. U. Weithmann may publish in the future.
Co-authors
The 25 scholars most cited alongside K. U. Weithmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 174 | |
| 2 | 1998 | 78 | |
| 3 | 1982 | 67 | |
| 4 | 1999 | 59 | |
| 5 | 2010 | 38 | |
| 6 | 1994 | 28 | |
| 7 | 1990 | 20 | |
| 8 | 1998 | 14 | |
| 9 | 1983 | 13 | |
| 10 | 1989 | 11 | |
| 11 | 1990 | 10 | |
| 12 | 1989 | 7 | |
| 13 | 1978 | 7 | |
| 14 | 1997 | 5 | |
| 15 | 1985 | 3 | |
| 16 | Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro. | 1989 | 2 |
| 17 | 1987 | 2 | |
| 18 | 1982 | 1 | |
| 19 | 1981 | 1 |
About K. U. Weithmann
K. U. Weithmann is a scholar working on Oncology, Molecular Biology, Pharmacology, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 19 papers that have together received 540 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Protease and Inhibitor Mechanisms (5 papers), Inflammatory mediators and NSAID effects (3 papers), Cell Adhesion Molecules Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Nitric Oxide and Endothelin Effects (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). The work is most often cited by research in Cancer Research (210 citations), Oncology (186 citations), Hematology (71 citations), Nephrology (37 citations) and Immunology and Allergy (31 citations). K. U. Weithmann has collaborated with scholars based in Germany, United States and Slovenia. Frequent co-authors include Alex Sevanian, K. Ulrich Wendt, Paul Hochstein, Bernard Pirard, Reinhard Kirsch, Otmar Klingler, Jörg Habermann, Christian K. Engel, D. Seiffge and Wilfried Schwab. Their work appears in journals such as Inflammation Research, Clinical Chemistry and Laboratory Medicine (CCLM), Biochemical Journal, Thrombosis and Haemostasis and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.